Search
The American Society of Human Genetics (ASHG) 2025 Annual Meeting taking place October 14–18 in Boston, Massachusetts, brings together the brightest minds in the field for five days of cutting-edge science, groundbreaking discoveries, and unparalleled networking opportunities.
Join Thermo Fisher Scientific at Booth 736 to experience and learn more about our genetic technologies and offerings, including two exciting new product launches.
We'll also be hosting a workshop and poster presentations. Don't miss this opportunity to interact and engage with our application scientists and learn more about how your applications and workflows can be enhanced by our technologies.
In-booth features
Next-generation genotyping system
Join us at our workshop on October 15 for a public unveiling of our latest innovation in genotyping. More information below.
Connect, automate, and secure. Orchestrate your lab efficiency with InnoviGene Suite, enabling a complete CE solution tailored to your specific needs.
SeqStudio Flex Genetic Analyzer
Enhanced flexibility meets trusted performance. Streamline your lab workflow with end-to-end Sanger sequencing and fragment analysis solutions.
Educational workshop
Genotyping breakthroughs in forensics and population genomics, with an exclusive live reveal
Date: Wednesday, October 15
Time: 12–1 pm
Location: Room 254AB
Lunch provided
Genotyping is unlocking new frontiers in human genetics, from advancing forensic investigations to enabling equitable precision medicine. Join Thermo Fisher Scientific for an electrifying lunch workshop featuring pioneering scientists and culminating in a can’t-miss exclusive live reveal of the future of microarray innovation.
Session 1: Forensic genotyping with an Axiom high-density human array
Jack Ballantyne, PhD, Professor, Department of Chemistry, and Interim Director, National Center for Forensic Science, University of Florida, will share findings from testing the Applied Biosystems Axiom High-Density SNP Genotyping Human Array on forensic-type DNA. His team evaluated low-input, degraded, and mixed samples to establish performance in sensitivity, reproducibility, and accuracy, with applications in forensic investigative genetic genealogy (FIGG). Results demonstrate the array’s strong potential to expand the toolkit of modern forensic science and meet FBI Quality Assurance Standards.
Session 2: Galatea—A population-specific genetic map of Greece
Nicholas Katsanis, PhD, Founder and Chief Science Officer, Galatea Bio, Inc., will highlight the first comprehensive genetic map of the Greek population built from ~8,000 participants across 12 clinics. Integrating genotyping and sequencing, the study reveals regional structure, admixture signatures, and enables ancestry-aware polygenic risk scores (PRS) tailored to Greek-specific allele frequencies. This work underscores the transformative power of microarrays in delivering equitable precision medicine for historically underrepresented populations.
Exclusive live reveal: The future of genotyping
To close, Thermo Fisher Scientific will take the stage to share our bold vision for the critical role microarrays will play in shaping the future of human genetics. Then, in a high-energy moment, we will debut our next-generation genotyping system in an exclusive live reveal. With a cinematic teaser video, words of inspiration from our leadership, and the Applied Biosystems system presented at its first public unveiling, this will be a truly unforgettable experience.
Be among the first to witness the next era of genotyping innovation—where groundbreaking science meets bold new technology.
Posters
Be sure to make time to check out our poster presentations. All posters will only be displayed for one day and are assigned a specific day/time to present.
Microarray
Detection of CYP2D6/CYP2D7 hybrid genes using the PharmacoPro array for pharmacogenomics research
Carsten Bruckner, Sr. Staff Scientist, Bioinformatics
Wednesday, October 15
2:30–4:30 pm
CNV detection for Pharmacogenetic and mental health research applications
Cevat Akin, Director, Engineering Systems Design
Wednesday, October 15
2:30–4:30 pm
Preemptive pharmacogenomic testing using the Axiom PharmacoPro Array
Alexa Barnes, Staff Scientist, Bioinformatics
Wednesday, October 15
2:30–4:30 pm
Reliable genotyping of APOE-ε4 and other markers in GC-rich regions with Axiom Workflow
Monica Chadha, Sr. Manager, Molecular Biology
Friday, October 17
2:30–4:30 pm
Novel Statistical Framework for Determining Dynamic Range in Oligonucleotide Microarray Platforms
Alex Choi, Manager, Systems Design Engineering
Friday, October 17
2:30–4:30 pm
Capillary electrophoresis
Performance Evaluation of the Applied Biosystems SeqStudio Flex Dx. An easy to use, efficient, and flexible capillary electrophoresis platform for Sanger sequencing and fragment analysis
Andy McNamara, Sr. Manager R&D, Capillary Electrophoresis Applications
Wednesday, October 15
2:30–4:30 pm
A new version of the Primer Designer on-line search tool for PCR-assays for clinical Sanger sequencing
Achim Karger Sr. Manager R&D, Capillary Electrophoresis
Wednesday, October 15
2:30–4:30 pm
Digital PCR
Streamlined analysis of DNA methylation and its functional consequences from FFPE tumor samples
Steve Jackson, Sr. Staff Product Applications Specialist
For Research Use Only. Not for use in diagnostic procedures.